INTRODUCTION {#sec1}
============

In many organisms, the Embden--Meyerhof variant of glycolysis catalyzes oxidation of glucose to pyruvate. The subsequent oxidative decarboxylation of pyruvate yields acetyl coenzyme A (acetyl-CoA), which can be fully oxidized to carbon dioxide in the tricarboxylic acid (TCA) cycle. In addition to their roles as dissimilatory pathways, glycolysis and TCA cycle provide key biosynthetic precursors. Both of these 'textbook' pathways have been intensively studied but, even in the intensively studied eukaryotic model organism *Saccharomyces cerevisiae*, their interface is less well understood.

Cytosolic pyruvate can be imported into the mitochondrial matrix via the transporters Mpc1, 2 and/or 3 (Bricker *et al*. [@bib6]; Herzig *et al*. [@bib36]). Direct oxidative decarboxylation by the mitochondrial pyruvate-dehydrogenase (PDH) complex yields acetyl-CoA in the mitochondrial matrix (pyruvate + NAD^+^ + CoA → acetyl-CoA~mit~ + NADH + H^+^ + CO~2~). *Null* mutants in *PDA1*, which encodes the essential E1α subunit of the PDH complex, show a reduced growth rate in aerobic batch cultures on glucose synthetic media (Wenzel *et al*. [@bib98]). Moreover, they exhibit an increased frequency of respiratory-deficient mutants and loss of mitochondrial DNA (Wenzel *et al*. [@bib98]). Alternatively, acetyl-CoA can be formed in the cytosol of *S. cerevisiae* via a reaction sequence known as the PDH bypass (Holzer and Goedde [@bib39]; Pronk, Steensma and Van Dijken [@bib73]), consisting of pyruvate decarboxylase (pyruvate → acetaldehyde + CO~2~), acetaldehyde dehydrogenase (acetaldehyde + NAD^+^ + H~2~O → acetate + NADH + H^+^) and acetyl-CoA synthetase (acetate + ATP + CoA ⇌ acetyl-CoA~cyt~ + AMP + PP~i~). Glucose-grown cultures of *S. cerevisiae*, which unlike many other eukaryotes does not contain ATP-citrate lyase (Boulton and Ratledge [@bib5]), depend on this route for synthesis of acetyl-CoA in the nucleocytosolic compartment, where it acts as a precursor for synthesis of lipids, *N*-acetylglucosamine, sterols and lysine (Oura [@bib68]; Flikweert *et al*. [@bib25], [@bib24]) and as acetyl donor for protein acetylation (Takahashi *et al*. [@bib81]; Henriksen *et al*. [@bib35]). An observed 13% reduction of the biomass yield on glucose of *pda1Δ* mutants in aerobic, glucose-limited chemostat cultures was quantitatively consistent with rerouting of respiratory pyruvate metabolism via the cytosolic, ATP-consuming PDH bypass (Pronk *et al*. [@bib74]).

The nucleocytosolic localization of acetyl-CoA synthetase in *S. cerevisiae* (Van den Berg and Steensma [@bib85]; Pronk, Steensma and Van Dijken [@bib73]; De Jong-Gubbels *et al*. [@bib12]; Takahashi *et al*. [@bib81]) implies that the PDH bypass cannot directly generate intramitochondrial acetyl-CoA. Two mechanisms might link glycolysis and the TCA cycle in PDH-negative *S. cerevisiae* mutants (Fig. [1](#fig1){ref-type="fig"}). First, cytosolic acetyl-CoA might be converted to citrate via the extramitochondrial citrate synthase isoenzyme Cit2 (Fig. [1](#fig1){ref-type="fig"}; Kispal *et al*. [@bib46]; Vélot *et al*. [@bib92]), followed by uptake of citrate via the mitochondrial transporter Ctp1 (Kaplan *et al*. [@bib43]). Alternatively, a transport or shuttle mechanism might catalyze translocation of cytosolic acetyl-CoA into the mitochondria.

![Mechanisms important for the provision of acetyl moieties in *S. cerevisiae* mitochondria. In glycolysis glucose is converted to pyruvate, which can be transported into the mitochondria via the mitochondrial pyruvate carriers Mpc1, Mpc2 and Mpc3, followed by its conversion to acetyl-CoA via the pyruvate dehydrogenase (PDH) complex. Alternatively, pyruvate can be converted to cytosolic acetyl-CoA via the pyruvate dehydrogenase bypass. Cytosolic acetyl-CoA can be condensed with oxaloacetate via Cit2 to form citrate, which can be exchanged with, for example, mitochondrial oxaloacetate, and hence fuel the TCA cycle. Acetate from the cytosol can also be activated to mitochondrial acetyl-CoA via Ach1 by transfer of the CoA group from succinyl-CoA to acetate. Only when cells are supplemented with [l]{.smallcaps}-carnitine, the carnitine shuttle can transport cytosolic acetyl units into the mitochondria. Abbreviations: α-KG, α-ketoglutarate; Acs1, Acs2, acetyl-CoA synthetase; Ach1, CoA transferase; ADH, alcohol dehydrogenase; ALD, acetaldehyde dehydrogenase; CAT, carnitine acetyltransferase; Cit2, citrate synthase; Crc1, acetyl-carnitine translocase; Mpc1, Mpc2, Mpc3, mitochondrial pyruvate carrier; OAA, oxaloacetate; PDC, pyruvate decarboxylase; PDH, pyruvate dehydrogenase complex.](fow017fig1){#fig1}

In many eukaryotes, the carnitine shuttle is responsible for translocation of acetyl moieties across organellar membranes. The carnitine shuttle involves cytosolic and organellar acetyl-CoA:carnitine O-acetyltransferases (acetyl-CoA + [l]{.smallcaps}-carnitine ⇌ acetyl-[l]{.smallcaps}-carnitine + CoA) (Bieber [@bib4]). In *S. cerevisiae*, acetyl-[l]{.smallcaps}-carnitine can be transported across the mitochondrial membrane by the mitochondrial acetyl-carnitine translocase Crc1 (Kohlhaw and Tan-Wilson [@bib50]; Palmieri *et al*. [@bib69]; Van Roermund *et al*. [@bib91]; Franken *et al*. [@bib27]). The three acetyl-carnitine transferases in *S. cerevisiae* have different subcellular localizations: Cat2 is peroxisomal and mitochondrial (Elgersma *et al*. [@bib19]), Yat1 is localized to the outer mitochondrial membrane (Schmalix and Bandlow [@bib77]) and Yat2 is reported to be cytosolic (Swiegers *et al*. [@bib80]; Huh *et al*. [@bib40]; Koh *et al*. [@bib49]). Since *S. cerevisiae* cannot synthesize [l]{.smallcaps}-carnitine *de novo*, activity of the carnitine shuttle is strictly dependent on uptake of exogenous [l]{.smallcaps}-carnitine via the Hnm1 transporter, whose expression is regulated by Agp2 (Van Roermund *et al*. [@bib90], [@bib91]; Swiegers *et al*. [@bib80]; Aouida *et al*. [@bib1]). Strong transcriptional repression of the carnitine shuttle structural genes by glucose (Kispal *et al*. [@bib45]; Schmalix and Bandlow [@bib77]; Elgersma *et al*. [@bib19]) would seem to prevent an important contribution in glucose-grown batch cultures, even when [l]{.smallcaps}-carnitine is present.

At least two metabolic processes in *S. cerevisiae* are strictly dependent on intramitochondrial acetyl-CoA. Although the bulk of lipid synthesis in *S. cerevisiae* occurs in the cytosol, long-chain fatty acids needed for lipoic acid biosynthesis are exclusively synthesized in the mitochondrial matrix (Brody *et al*. [@bib7]). Additionally, arginine biosynthesis requires catalytic amounts of intramitochondrial acetyl-CoA (Jauniaux, Urrestarazu and Wlame [@bib42]). The ability of *pda1Δ* mutants to grow on glucose in synthetic media lacking [l]{.smallcaps}-carnitine indicates that, in addition to the PDH complex, *S. cerevisiae* must contain at least one other mechanism for mitochondrial acetyl-CoA provision. Ach1, a key candidate for this role, was first described as an acetyl-CoA hydrolase (Lee, Lin and Smith [@bib57]; Buu, Chen and Lee [@bib8]). Later, it was demonstrated to have in fact a much higher *in vitro* activity for the transfer of the CoA group from various acyl-CoA substrates to other organic acids (Fleck and Brock [@bib23]). One such reaction involves the transfer of the CoA-group from succinyl-CoA to acetate, forming acetyl-CoA (succinyl-CoA + acetate ⇌ acetyl-CoA + succinate). This Ach1 catalyzed reaction could generate mitochondrial acetyl-CoA from acetate, derived from the PDH bypass, and mitochondrial succinyl-CoA, derived from the TCA cycle (via the α-ketoglutarate dehydrogenase complex) or via ATP-dependent activation of succinate by succinyl-CoA ligase (succinate + ATP + CoA ⇌ succinyl-CoA + ADP + P~i~). Although a role of Ach1 in mitochondrial acetyl-CoA synthesis has been shown before (Fleck and Brock [@bib23]; Orlandi, Casatta and Vai [@bib67]; Eisenberg *et al*. [@bib18]), its significance in glucose-grown batch cultures of wild-type and mutant *S. cerevisiae* strains remains to be elucidated.

The aim of the present study is to assess the relative importance of different alternative reactions active at the interface of glycolysis and TCA cycle in *S. cerevisiae* strains that lack a functional PDH complex. To this end, we reinvestigated growth of *pda1Δ S. cerevisiae* on glucose in synthetic medium and analyzed the effects of additional *null* mutations in *ACH1* and *CIT2* on growth rate, respiratory competence and metabolite formation. Moreover, we investigate whether constitutive expression of carnitine-shuttle genes enables the carnitine shuttle to function as an effective link between glycolysis and TCA cycle in glucose-grown batch cultures supplemented with [l]{.smallcaps}-carnitine.

MATERIALS AND METHODS {#sec2}
=====================

Growth media {#sec2-1}
------------

Yeast-extract/peptone (YP) medium was prepared with demineralized water, 10 g ⋅ L^−1^ Bacto yeast extract (BD, Franklin Lakes, NJ, USA) and 20 g ⋅ L^−1^ Bacto peptone (BD). Synthetic medium with ammonium as nitrogen source (SM-ammonium) was prepared according to Verduyn *et al*. ([@bib94]). Synthetic medium with other nitrogen sources was prepared similarly, but with 38 mM K~2~SO~4~ instead of (NH~4~)~2~SO~4~ and with 38 mM urea (SM-urea), 76 mM [l]{.smallcaps}-glutamate (SM-glutamate). These modifications were made to maintain equivalent concentrations of nitrogen and sulfate relative to the original medium description. Media with these alternative nitrogen sources were sterilized with 0.2 μm bottle-top filters (Thermo Fisher Scientific, Waltham, MA, USA). Solid media were prepared by addition of 20 g ⋅ L^−1^ agar (BD) prior to heat sterilization of the medium for 20 min at 121°C.

Strains, growth conditions and storage {#sec2-2}
--------------------------------------

The *S. cerevisiae* strains used in this study (Table [1](#tbl1){ref-type="table"}) share the CEN.PK genetic background (Entian and Kötter [@bib20]; Nijkamp *et al*. [@bib66]). Shake-flask cultures were grown at 30°C in 500 mL flasks containing 100 mL SM-ammonium with 20 g⋅L^−1^ glucose, in an Innova incubator shaker (New Brunswick Scientific, Edison, NJ, USA) set at 200 rpm. Stock cultures were grown in YP medium with 20 g⋅L^−1^ glucose. For strains IMK640, IMK641, IMX710 and IMX744, 2% (v/v) ethanol was used as carbon source to prevent loss of respiratory competence. Frozen stocks were prepared by adding 30% (v/v) glycerol to exponentially growing cultures and stored in 1 mL aliquots at −80°C. To induce sporulation, strains were pre-grown in YP medium with 10 g⋅L^−1^ potassium acetate, followed by incubation in sporulation medium (demineralized water, 20 g⋅L^−1^ potassium acetate, pH 7.0) (Fast [@bib21]).

###### 

*Saccharomyces cerevisiae* strains used in this study and their relevant genotypes.

  Name           Relevant genotype                                                                              Parental strain(s)   Origin
  -------------- ---------------------------------------------------------------------------------------------- -------------------- -------------------------------------
  CEN.PK113-7D   *MAT*a                                                                                                              P. Kötter
  IMK439         *MATα ura3Δ::loxP-kanMX-loxP*                                                                  CEN.PK113-1A         González-Ramos *et al*. ([@bib31a])
  IMX585         *MAT*a *can1Δ::cas9-natNT2*                                                                    CEN.PK113-7D         Mans *et al*. ([@bib64])
  CEN.PK541-1A   *MAT*a *pda1Δ::loxP-kanMX-loxP*                                                                                     This study
  CEN.PK542-1A   *MAT*α *cit2Δ::loxP-kanMX-loxP*                                                                                     This study
  CEN.PK544-4D   *MAT*a *pda1Δ::loxP-kanMX-loxP cit2Δ::loxP-kanMX-loxP*                                                              This study
  IMK627         *MAT*a *ach1Δ::loxP-natNT2-loxP*                                                               CEN.PK113-7D         This study
  IMK629         *MAT*α *cit2Δ::loxP-kanMX-loxP ach1Δ::loxP-natNT2-loxP*                                        CEN.PK542-1A         This study
  IMK640         *MAT*a *pda1Δ::loxP-kanMX-loxP ach1Δ::loxP-natNT2-loxP*                                        CEN.PK541-1A         This study
  IMK641         *MAT*a *pda1Δ::loxP-kanMX-loxP cit2Δ::loxP-kanMX-loxP ach1Δ::loxP-natNT2-loxP*                 CEN.PK544-4D         This study
  IMX710         *MAT*a *can1Δ::cas9-natNT2 pda1Δ ach1Δ*                                                        IMX585               This study
  IMX744         *MAT*a *can1Δ::cas9-natNT2 pda1Δ ach1Δ sga1Δ::*{CARN}^a^                                       IMX710               This study
  IMD015         *MAT*α *ura3Δ::loxP-kanMX-loxP* × *MAT*a *URA3 can1Δ::cas9-natNT2 pda1Δ ach1Δ sga1Δ::*{CARN}   IMK439 × IMX744      This study
  IMX868         *MAT*α *can1Δ::cas9-natNT2 URA3 PDA1 ACH1 sga1Δ::*{CARN}                                       IMD015               This study

^a^{CARN}, *pTDH3-AGP2-tAGP2 pPGK1-HNM1-tHNM1 pADH1-YAT2-tYAT2 pPGI1-YAT1-tYAT1 pTPI1-CRC1-tCRC1 pTEF1-CAT2-tCAT2*.

Strain and plasmid construction {#sec2-3}
-------------------------------

*Saccharomyces cerevisiae* strains were transformed according to Gietz & Woods ([@bib30]). Mutants were selected on solid YP medium, supplemented with 20 g⋅L^−1^ glucose and the appropriate antibiotic, 200 mg⋅L^−1^ G418 (InvivoGen, San Diego, CA, USA) or 100 mg⋅L^−1^ nourseothricin (Jena Bioscience, Jena, Germany). SM containing 10 mM acetamide as the sole nitrogen source (SM-acetamide) was used for selection of the *amdSYM* marker (Solis-Escalante *et al*. [@bib79]). Deletion cassettes for *PDA1* and *CIT2* were constructed with a PCR-based method using pUG6 as template (Güldener *et al*. [@bib33]), using primer pairs 9087 & 9088 and 9089 & 9090, respectively. Thus amplified *kanMX* cassettes were used to replace the target genes in the prototrophic diploid strain CEN.PK122 (*MAT*a/*MAT*α). Transformants were verified for correct gene replacement by diagnostic PCR (Table S1, Supporting Information). After sporulation and tetrad dissection, the haploid deletion strains CEN.PK541-1A (*MAT*a *pda1Δ*) and CEN.PK542-1A (*MAT*α *cit2Δ*) were obtained. To obtain a strain with both *CIT2* and *PDA1* deleted, strains CEN.PK541-1A and CEN.PK542-1A were crossed. After tetrad dissection, spores showing the non-parental ditype for the *kanMX* marker were analyzed by diagnostic PCR to confirm correct deletion of both genes, resulting in strain CEN.PK544-4D (*MAT*a *pda1Δ cit2Δ*). Deletion of *ACH1* in strains CEN.PK113-7D, CEN.PK542-1A, CEN.PK541-1A and CEN.PK544-4D was achieved by integration of the *natNT2* marker into its locus. The *natNT2* cassette was PCR amplified from pUG-natNT2 (De Kok *et al*. [@bib13]) with primer pair 3636 & 3637. Correct deletion was verified by colony PCR (Lõoke, Kristjuhan and Kristjuhan [@bib62]) using the primers shown in Table S1 (Supporting Information), resulting in strains IMK627, IMK629, IMK640 and IMK641, respectively.

IMX710 was constructed by removing *PDA1* and *ACH1* in strain IMX585 using the CRISPR/Cas9 system by introduction of a plasmid containing two guideRNA (gRNA) cassettes, targeting *PDA1* and *ACH1*. The plasmid was constructed as described before (Mans *et al*. [@bib64]) with primers 5794 & 6159 to incorporate the appropriate target sites and with pROS13 as a backbone, resulting in plasmid pUDE340. Strain IMX585 was transformed with plasmid pUDE340 together with the repair fragments that were obtained by annealing oligonucleotides 6157 & 6158 (*PDA1* deletion) and 6160 & 6161 (*ACH1* deletion). After confirmation of the gene deletions using diagnostic PCR (Table S1, Supporting Information), plasmid pUDE340 was removed as described before (Mans *et al*. [@bib64]), resulting in strain IMX710.

Strain IMX744 was obtained by placing the genes encoding the carnitine shuttle proteins (*HNM1*, *AGP2*, *CRC1*, *YAT1*, *YAT2* and *CAT2*), under control of strong constitutive promoters and integrating them into the *SGA1* locus. *SGA1* encodes a glucoamylase that is not expressed during vegetative growth of *S. cerevisiae* (Yamashita and Fukui [@bib99]). Its inactivation was therefore considered to be neutral under the conditions employed in this study. For this purpose, the constitutive promoters *pTPI1*, *pTDH3*, *pADH1*, *pTEF1*, *pPGK1* and *pPGI1* were amplified by PCR from plasmids pUD301--pUD306 (Kozak *et al*. [@bib52]) (Table S2 and S3, Supporting Information). The ORFs of the six genes involved in the carnitine shuttle, together with their terminator sequences, were amplified from the CEN.PK113-7D genome and fused to the constitutive promoters with fusion PCR (Yon and Fried [@bib100]) (See Table S3, Supporting Information, for primers and templates). Gene cassettes were ligated in pJET1.2 (Life Technologies, Carlsbad, CA, USA) and the resulting plasmids (pUD366--pUD371; Table S2, Supporting Information) were verified by Sanger sequencing (BaseClear BV, Leiden, The Netherlands). The plasmid with the gRNA cassette targeting *SGA1* (pUDR119) was constructed by Gibson Assembly of the pMEL11 backbone (Mans *et al*. [@bib64]), obtained by PCR with pMEL11 as a template and using primers 5792 & 5980, and the gRNA cassette, obtained by PCR with primers 5979 & 7023 using the same template. Strain IMX710 was transformed with plasmid pUDR119 and the six gene cassettes, amplified from plasmids pUD366--pUDE371 with PCR using primers as indicated in Table S3 (Supporting Information). The six gene cassettes were concatenated via *in vivo* homologous recombination, mediated by 60 bp overlapping sequences, and after a Cas9-induced double-strand break, integrated into the *SGA1* locus (see Data 1, Supporting Information for sequence in GenBank format). After confirmation of correct integration by diagnostic PCR (for primers see Table S1, Supporting Information), pUDR119 was removed as described before (Mans *et al*. [@bib64]), resulting in strain IMX744 (*MAT*a *can1Δ::cas9-natNT2 pda1Δ ach1Δ sga1Δ::*{*pTDH3-AGP2-tAGP2 pPGK1-HNM1-tHNM1 pADH1-YAT2-tYAT2 pPGI1-YAT1-tYAT1 pTPI1-CRC1-tCRC1 pTEF1-CAT2-tCAT2*}). The set of genes that are involved in the carnitine shuttle and introduced in the *SGA1* locus are further referred to as {CARN}.

IMX868 was obtained by crossing, sporulation and spore dissection. Strain IMX744 (*MAT*a) was crossed with IMK439 (*MAT*α) by selecting for diploids on YP medium with 20 g·L^−1^ glucose, G418 and nourseothricin. The resulting diploid IMD015 was sporulated and the asci were dissected on YP with 20 g·L^−1^ glucose using a micromanipulator (Singer Instruments, Watchet, UK). One spore with the desired genotype (*PDA1 ACH1 URA3 sga1Δ::*{CARN}) was stocked as IMX868.

Molecular biology techniques {#sec2-4}
----------------------------

PCR amplification with Phusion^®^ Hot Start II High Fidelity Polymerase (Thermo Fisher Scientific) was performed according to the manufacturer\'s instructions using HPLC- or PAGE-purified oligonucleotide primers (Sigma-Aldrich). Diagnostic PCR was done via colony PCR on randomly picked yeast colonies, using DreamTaq (Thermo Fisher Scientific) and desalted primers (Sigma-Aldrich). DNA fragments obtained by PCR were separated by gel electrophoresis on 1% (w/v) agarose gels (Thermo Fisher Scientific) in TAE buffer (Thermo Fisher Scientific) at 100 V for 30 min. Alternatively, fragments were purified using the GenElute PCR Clean-Up Kit (Sigma-Aldrich). Plasmids were isolated from *Escherichia coli* with Sigma GenElute Plasmid kit (Sigma-Aldrich) according to the supplier\'s manual. Yeast genomic DNA was isolated using a YeaStar Genomic DNA kit (Zymo Research) or using an SDS/LiAc-based lysis protocol (Lõoke, Kristjuhan and Kristjuhan [@bib62]). *E. coli* DH5α (18258--012, Life Technologies) was used for chemical transformation or for electroporation. Chemical transformation was done according to Inoue, Nojima and Okayama ([@bib41]). Electrocompetent DH5α cells were prepared according to Bio-Rad\'s protocol, with the exception that during the preparation of competent cells, *E. coli* was grown in LB medium without NaCl. Electroporation was done in a 2 mm cuvette (165--2086, Bio-Rad, Hercules, CA, USA) using a Gene Pulser Xcell Electroporation System (Bio-Rad), following the manufacturer\'s protocol.

Growth studies on urea and l-glutamate as nitrogen source {#sec2-5}
---------------------------------------------------------

Growth studies were conducted at 30°C in 500-mL flasks. To prevent nutrient carry over from stock cultures, strains were pre-grown in two sequential shake flasks in which biomass formation was not limited by the amount of carbon source but by the nitrogen source. To this end, 200-μL cell suspension from frozen stocks were inoculated in 100 mL SM-glutamate with a decreased initial [l]{.smallcaps}-glutamate concentration of 1.5 mM and with 20 g⋅L^−1^ glucose. After reaching stationary phase, biomass was centrifuged (4°C, 5 min at 3000 g). The pellet was washed twice with demineralized water, resuspended in demineralized water and used to inoculate a second shake flask with the same medium. After reaching stationary phase, the same wash procedure was performed and a final set of shake flasks, containing either 100 mL SM-urea or SM-glutamate and 20 g⋅L^−1^ glucose, was inoculated for growth rate determination,. Where indicated, [l]{.smallcaps}-carnitine (Sigma-Aldrich) was added at a final concentration of 0.4 g⋅L^−1^. Optical density at 660 nm was measured at regular time intervals with a Libra S11 spectrophotometer (Biochrom, Cambrige, UK).

Batch and chemostat cultures in bioreactors {#sec2-6}
-------------------------------------------

Controlled batch and chemostat cultures were grown at 30°C in 2-L bioreactors (Applikon, Schiedam, The Netherlands) with working volumes of 1 L. Pre-cultures for batch cultivation were grown in shake flasks containing 100 mL SM-urea and 20 g⋅L^−1^ glucose. Pre-cultures for chemostat experiments were grown in shake flasks with 100 mL SM-glutamate and 20 g⋅L^−1^ glucose. Before inoculation of the bioreactors, pre-cultures were washed once with demineralized water. During the batch phase in bioreactors, cells were grown in SM-ammonium (Verduyn *et al*. [@bib94]) with 20 g⋅L^−1^ glucose and 0.3 g⋅L^−1^ antifoam Pluronic PE 6100 (BASF, Ludwigshafen, Germany). When a rapid decrease in CO~2~ production indicated glucose depletion, continuous cultivation was initiated at a dilution rate of 0.05 h^−1^. During this chemostat phase, cells were grown on SM-ammonium with 7.5 g⋅L^−1^ glucose and 0.15 g⋅L^−1^ antifoam Pluronic PE 6100. Culture pH was maintained at 5.0 by automatic addition of 2 M KOH. Where indicated, 0.04 g⋅L^−1^[l]{.smallcaps}-carnitine was added to a sterilized bioreactor or medium vessel from a filter-sterilized stock of 40 g⋅L^−1^. To ensure fully aerobic conditions, the bioreactors were sparged with 500 mL⋅min^−1^ air and stirred at 800 rpm.

Analytical methods and calculations {#sec2-7}
-----------------------------------

Chemostat steady-state samples were taken between 7 and 12 volume changes after inoculation. Chemostats with CEN.PK113-7D were assumed to be in steady state when, after at least five volume changes, carbon dioxide production rates changed by less than by 4% over two volume changes. Due to selective pressure in the chemostats, IMK640 did not reach this requirement and was sampled after 7--12 volume changes. Dry weight measurements, HPLC analysis of supernatants and off-gas analysis were performed as described previously (De Kok *et al*. [@bib14]). Biomass-specific production rates of ethanol were corrected for evaporation as described previously (Guadalupe Medina *et al*. [@bib32]). Samples for analysis of extracellular metabolite concentrations (e.g. residual glucose) were taken with the stainless-steel-bead rapid-quenching method (Mashego *et al*. [@bib65]). HPLC quantification of acetaldehyde measurements were performed as described previously (Bekers, Heijnen and Van Gulik [@bib2]) with some modifications (Kozak *et al*. [@bib51]).

For aerobic batch cultures, maximum specific growth rates (μ~max~) in the glucose phase were calculated via linear regression of the natural logarithm of at least five OD~660~ measurements. Biomass yield on substrate (Y~X/S~ in g dry weight⋅(mmol glucose)^−1^) and product yields on substrate (Y~i/S~ in mol⋅(mol glucose)^−1^) were calculated via linear regression on at least three experimental data points, with an interval of at least 2 h. Maximum biomass-specific glucose consumption rates (q~S~^max^) were calculated by dividing μ~max~ by Y~X/S~ and maximum biomass specific production rates were calculated by multiplying the ratio of produced compound over produced biomass by μ~max~, based on the assumption that growth stoichiometries remained constant during the exponential growth phase.

Determination of accumulation of respiratory deficient mutants {#sec2-8}
--------------------------------------------------------------

Shake flasks with YP and 2% (v/v) ethanol were inoculated from frozen stocks. Stationary-phase cultures were used to inoculate new 100-mL shake flasks, with 20 mL SM-glutamate and 20 g⋅L^−1^ glucose at an estimated initial OD~660~ of 0.001. After 12 generations (based on OD~660~ measurements), ∼100 cells per plate were applied on solid YP medium containing 20 g⋅L^−1^ glucose. Colonies were replica plated on YP with 2% ethanol and YP with 20 g⋅L^−1^ glucose. The number of colonies on each medium was counted and the fraction of respiratory-deficient mutants was estimated from the fraction of the colonies that grew on YP-glucose medium but not on YP-ethanol medium. Two independent plating experiments were performed for each strain, with 10 plates per experiment.

Carnitine acetyltransferase enzyme assay {#sec2-9}
----------------------------------------

Culture samples (corresponding to ca. 62.5 mg dry weight), harvested from exponentially growing shake flasks cultures on SM-ammonium with 20 g⋅L^−1^ glucose, were washed, stored and prepared as described previously (Postma *et al*. [@bib72]). Cell extracts were prepared with a FastPrep-24 machine (M.P. Biomedicals, Irvine, CA, USA) using four bursts of 20 s at a speed of 6.0 m⋅s^−1^ with 30 s cooling intervals at 0°C as described before (De Kok *et al*. [@bib14]). After removal of cells and debris by centrifugation (4°C, 20 min at 48 000 g), the supernatant was used for enzyme assays. Carnitine acetyltransferase activity was measured at 30°C on a Hitachi model U-3010 spectrophotometer (Sysmex, Norderstedt, Germany) by monitoring absorbance at 412 nm, which is proportional to the amount of free CoA (Fritz *et al*. [@bib28]). The reaction mixture, with a final volume of 1 mL, contained 100 mM Tris-HCl (pH 8), 0.5 mM acetyl-CoA, 0.1 mM DTNB and cell extract. The reaction was started by adding 40 μL of 1 M [l]{.smallcaps}-carnitine solution, to a final concentration of 40 mM. Enzyme activities were calculated using Beer\'s law with an extinction coefficient (ɛ) for TNB^2−^ of 14.15 mM^−1^⋅cm^−1^ (Riddles, Blakeley and Zerner [@bib76]). To determine the quality of the cell extracts, and thereby to eliminate poor extract quality as the cause of the absence of carnitine acetyltransferase activity in some cultures, activity of glucose-6-phosphate dehydrogenase was determined as described previously (Postma *et al*. [@bib72]). Reaction rates were proportional to the amounts of cell extract added. Enzyme activities were measured in cell extracts from two independently grown shake flask cultures. Protein concentrations in cell extracts were determined with the Lowry method (Lowry *et al*. [@bib63]).

RESULTS {#sec3}
=======

Determination of the specific growth rates of *pda1Δ*, *cit2Δ* and *ach1Δ* mutants {#sec3-1}
----------------------------------------------------------------------------------

Studying the interface between glycolysis and the TCA cycle in *S. cerevisiae* is complicated by the different possible fates of mitochondrial acetyl-CoA: direct use for synthesis of arginine, leucine and lipoate; complete dissimilation via the TCA cycle; and generation of TCA-cycle intermediates as biosynthetic precursors. Only the first of these fates is strictly dependent on availability of intramitochondrial acetyl-CoA. To assess the relevance of the PDH complex, Cit2 and Ach1 (Fig. [1](#fig1){ref-type="fig"}) for the three processes indicated above, specific growth rates of deletion mutants were determined in glucose synthetic medium with either urea or glutamate as the nitrogen source. Of these two nitrogen sources, only glutamate can yield α-ketoglutarate and, thereby, provide an alternative source of TCA-cycle intermediates as biosynthetic precursors.

In glucose-grown cultures with glutamate as the nitrogen source, only strains IMK640 (*pda1Δ ach1Δ*) and IMK641 (*pda1Δ cit2Δ ach1Δ*) showed substantially lower specific growth rates than the reference strain CEN.PK113-7D, while single deletions of *PDA1*, *CIT2* or *ACH1* did not affect growth (Table [2](#tbl2){ref-type="table"}). In *S. cerevisiae*, activity of either the PDH complex or Ach1 therefore appears to be enough to provide sufficient intramitochondrial acetyl-CoA for synthesis of arginine, leucine and lipoate. Consistent with the hypothesis that mitochondrial acetyl-CoA availability is limiting growth, addition of [l]{.smallcaps}-carnitine, which enables supply of intramitochondrial acetyl-CoA via the carnitine shuttle, led to a 67%--94% increase of the specific growth rates of the *pda1Δ ach1Δ* and *pda1Δ cit2Δ ach1Δ* mutants (Table [2](#tbl2){ref-type="table"}).

###### 

Effect of removing key reactions at the interface between glycolysis and TCA cycle interface on the specific growth rate on glucose. Strains were grown in shake flask cultures on synthetic medium with 20 g⋅L^−1^ glucose with either 38 mM urea or 76 mM glutamate as the sole nitrogen source. Where indicated, [l]{.smallcaps}-carnitine was added at a final concentration of 400 mg⋅L^−1^. The data represent averages of at least two independent experiments. In all cases the mean deviation was ≤ 0.01 h^−1^.

                           Specific growth rate (h^−1^)                                  
  -------------- --------- ------------------------------ --------- ------ ------ ------ ------
  CEN.PK113-7D   *PDA1*    *CIT2*                         *ACH1*    0.35   0.37   0.35   0.38
  CEN.PK541-1A   *pda1Δ*   *CIT2*                         *ACH1*    0.19   0.34   0.19   0.33
  CEN.PK542-1A   *PDA1*    *cit2Δ*                        *ACH1*    0.34   0.36          
  IMK627         *PDA1*    *CIT2*                         *ach1Δ*   0.34   0.36          
  IMK629         *PDA1*    *cit2Δ*                        *ach1Δ*   0.34   0.36          
  IMK640         *pda1Δ*   *CIT2*                         *ach1Δ*   0.10   0.09   0.13   0.16
  CEN.PK544-4D   *pda1Δ*   *cit2Δ*                        *ACH1*    0.05   0.33   0.09   0.33
  IMK641         *pda1Δ*   *cit2Δ*                        *ach1Δ*   0.04   0.09   0.09   0.17

With urea as a nitrogen source, CEN.PK541-1A (*pda1Δ*) showed a 45% lower specific growth rate than the reference strain, while IMK627 (*ach1Δ*) showed near wild-type growth rates. This result is consistent with an earlier report, based on glucose-limited chemostat cultures, that the PDH complex is the predominant link between glycolysis and TCA cycle in *S. cerevisiae* (Pronk *et al*. [@bib74]). Similar specific growth rates of the IMK640 (*pda1Δ ach1Δ*) strain on urea and glutamate media suggested that the observed reduction in those growth rates in comparison to the reference strain was not caused by a shortage of TCA-cycle intermediates. Additional disruption of *CIT2* (strain IMK641, *pda1Δ cit2Δ ach1Δ*) led to even slower growth on urea, while the growth rate on glutamate medium was the same as that of the *pda1Δ ach1Δ* strain. This observation indicates that Cit2 is involved in funnelling TCA-cycle intermediates into the mitochondria in the *pda1Δ ach1Δ* strain during growth on urea medium. Additionally, strain CEN.PK544-4D (*pda1Δ cit2Δ*) showed strongly impaired growth on urea media (0.05 h^−1^), but near wild-type rates on glutamate (0.34 h^−1^). Together with the observation that with glutamate as a nitrogen source, CEN.PK544-4D (*pda1Δ cit2Δ ACH1*) shows much faster growth than IMK641 (*pda1Δ cit2Δ ach1Δ*), these growth experiments support the conclusion that Ach1 is sufficiently active to cover the major requirement for intramitochondrial acetyl-CoA as a precursor of arginine, leucine and lipoate biosynthesis. However, Ach1 cannot meet the entire demand of acetyl-CoA for dissimilation via the TCA cycle and for the generation of TCA-cycle intermediates and intramitochondrial acetyl-CoA as metabolic precursors. The residual growth of strain IMK641 (*pda1Δ cit2Δ ach1Δ*, 0.04 h^−1^ on urea medium) indicates that, in *S. cerevisiae*, at least one other mechanism can generate intramitochondrial acetyl-CoA.

Strains with decreased availability of mitochondrial acetyl-CoA show increased loss of respiration {#sec3-2}
--------------------------------------------------------------------------------------------------

An increased incidence of respiratory deficient mutants, often associated with loss of mitochondrial DNA (rho^−^*petites*) has been observed for several mutants in genes encoding components of the mitochondrial fatty-acid synthase system (Harington *et al*. [@bib34]; Torkko *et al*. [@bib83]; Hiltunen *et al*. [@bib37]). Moreover, strains with reduced mitochondrial malonyl-CoA synthesis due to absence of the mitochondrial acetyl-CoA carboxylase Hfa1 exhibit a decreased lipoate content and loss of respiratory competence (Hoja *et al*. [@bib38]). An increased incidence of rho^0^*petites* has also been observed in Pdh^−^ strains (Wenzel *et al*. [@bib98]). To investigate the impacts of deleting *PDA1*, *CIT2* and/or *ACH1* on respiratory competence, we analyzed loss of the ability to grow on the non-fermentable carbon source ethanol, after 12 generations of growth on synthetic medium with 20 g·L^−1^ glucose and glutamate. Most strains showed a low incidence of respiratory-deficient cells (Table [3](#tbl3){ref-type="table"}). However, the two strains in which both routes of mitochondrial acetyl-CoA provision were disrupted, IMK640 (*pda1Δ ach1Δ*) and IMK641 (*pda1Δ cit2Δ ach1Δ*), displayed a spectacularly high incidence of respiratory deficient cells (94% and 92%, respectively). This result strengthened the conclusion that presence of either an active PDH complex or of Ach1 is essential for sufficient supply of intramitochondrial acetyl-CoA and that the role of Cit2 in *pda1Δ* mutants (Table [2](#tbl2){ref-type="table"}) is limited to the provision of TCA-cycle intermediates.

###### 

Effect of removing key reactions at the glycolysis-TCA cycle interface on loss of respiratory competence in *S. cerevisiae*. After initial growth in YP with 2% (v/v) ethanol, cells were transferred to SM with 20 g⋅L^−1^ glucose and 76 mM glutamate as nitrogen source. After 12 generations, the cultures were plated on YP with 20 g⋅L^−1^ glucose. After colonies were observed, the plates were replica plated on YP with 2% (v/v) ethanol and YP with 20 g⋅L^−1^ glucose. Percentages of cells unable to grow on YP with 2% (v/v) ethanol are based on independent duplicate experiments, with 10 plates per strain per experiment and ∼100 cells per plate. Standard deviations are based on 20 plates per strain.

                           Respiratory deficient             
  -------------- --------- ----------------------- --------- --------------
  CEN.PK113-7D   *PDA1*    *CIT2*                  *ACH1*    0.00 ± 0.00
  CEN.PK541-1A   *pda1Δ*   *CIT2*                  *ACH1*    0.12 ± 0.31
  CEN.PK542-1A   *PDA1*    *cit2Δ*                 *ACH1*    0.15 ± 0.37
  IMK627         *PDA1*    *CIT2*                  *ach1Δ*   0.16 ± 0.40
  IMK629         *PDA1*    *cit2Δ*                 *ach1Δ*   0.14 ± 0.45
  IMK640         *pda1Δ*   *CIT2*                  *ach1Δ*   93.88 ± 4.29
  CEN.PK544-4D   *pda1Δ*   *cit2Δ*                 *ACH1*    0.07 ± 0.21
  IMK641         *pda1Δ*   *cit2Δ*                 *ach1Δ*   92.13 ± 1.85

[l]{.smallcaps}-Carnitine supplementation enables respiratory growth in glucose-limited cultures of a *pda1Δ ach1Δ* strain {#sec3-3}
--------------------------------------------------------------------------------------------------------------------------

As the *pda1Δ ach1Δ* genotype stimulates loss of respiratory competence, IMK640 (*pda1Δ ach1Δ*) was further characterized in aerobic, glucose-limited chemostat cultures at a dilution rate of 0.05 h^−1^. Under these conditions, sugar dissimilation of wild-type *S. cerevisiae* strains is fully respiratory (Van Dijken *et al*. [@bib86]; Van Hoek, Van Dijken and Pronk [@bib88]). Conversely, strain IMK640 (*pda1Δ ach1Δ*) showed respirofermentative sugar metabolism under these conditions, as evident from the production of ethanol and a 69% lower biomass yield on glucose compared to the reference strain (Table [4](#tbl4){ref-type="table"}).

###### 

Physiology of the *S. cerevisiae* reference strain CEN.PK113-7D and IMK640 (*pda1Δ ach1Δ*) in aerobic glucose-limited chemostat cultures with or without 40 mg⋅L^−1^[l]{.smallcaps}-carnitine at a dilution rate of 0.05 h^−1^. Averages and mean deviations from CEN.PK113-7D and IMK640 were obtained from respectively two and four replicates. The respiratory quotient is the absolute value of q~CO~2~~/q~O~2~~. Biomass specific consumption (q~glucose~) and production rates (q~product~) are expressed in mmol⋅g~DW~^−1^⋅h^−1^ and the biomass yield on glucose (Y~x/s~) in g⋅g^−1^.

                                            CEN.PK113-7D (*PDA1 ACH1*)               IMK640 (*pda1Δ ach1Δ*)                         IMK640 (*pda1Δ ach1Δ*)
  ---------------------- ------------------ ---------------------------------------- ---------------------------------------------- ----------------------------------------------
  Biomass dry weight     g⋅L^−1^            3.46 ± 0.12                              1.07 ± 0.08                                    2.72 ± 0.04
  Y~x/s~                 g⋅g^−1^            0.49 ± 0.01                              0.15 ± 0.01                                    0.37 ± 0.01
  Respiratory quotient                      1.06 ± 0.02                              1.64 ± 0.13                                    0.97 ± 0.08
  q~glucose~             mmol⋅g^−1^⋅h^−1^   −0.57 ± 0.01                             −1.87 ± 0.11                                   −0.74 ± 0.03
  q~O~2~~                mmol⋅g^−1^⋅h^−1^   −1.49 ± 0.05                             −2.55 ± 0.19                                   −2.24 ± 0.33
  q~ethanol~             mmol⋅g^−1^⋅h^−1^   0.00 ± 0.00                              1.26 ± 0.16                                    0.03 ± 0.04
  q~CO~2~~               mmol⋅g^−1^⋅h^−1^   1.57 ± 0.03                              4.17 ± 0.18                                    2.13 ± 0.10
  q~pyruvate~            mmol⋅g^−1^⋅h^−1^   0.00 ± 0.00                              0.03 ± 0.01                                    0.00 ± 0.00
  q~glycerol~            mmol⋅g^−1^⋅h^−1^   0.00 ± 0.00                              0.03 ± 0.01                                    0.00 ± 0.00
  q~acetate~             mmol⋅g^−1^⋅h^−1^   0.00 ± 0.00                              0.15 ± 0.02                                    0.00 ± 0.00
  q~succinate~           mmol⋅g^−1^⋅h^−1^   0.00 ± 0.00                              0.10 ± 0.05                                    0.02 ± 0.00
  q~citrate~             mmol⋅g^−1^⋅h^−1^   0.00 ± 0.00                              0.07 ± 0.01                                    0.00 ± 0.00
  q~acetaldehyde~        mmol⋅g^−1^⋅h^−1^   N.D.[\*](#TFN002){ref-type="table-fn"}   0.13 ± 0.01[1](#TFN003){ref-type="table-fn"}   0.00 ± 0.00[2](#TFN003){ref-type="table-fn"}
  Residual glucose       mmol⋅L^−1^         0.13 ± 0.06                              0.49 ± 0.02                                    0.18 ± 0.06

N.D., not detected.

Average from three replicates.

Average from two replicates.

In aerobic, glucose-limited chemostat cultures, the genes encoding the multiple components of the carnitine shuttle are derepressed (Fig. S1, Supporting Information). When such cultures of strain IMK640 (*pda1Δ ach1Δ*) were supplemented with [l]{.smallcaps}-carnitine, their physiology became fully respiratory, indicated by the absence of ethanol production, a decreased respiratory quotient and an increased biomass yield on glucose (Table [4](#tbl4){ref-type="table"}). The 24% lower biomass yield of strain IMK640 relative to the *PDA1 ACH1* reference strain (Table [4](#tbl4){ref-type="table"}) is consistent with increased ATP consumption as a result of redirection of respiratory pyruvate dissimilation via the PDH bypass (Pronk *et al*. [@bib74]).

Constitutive expression of the carnitine shuttle enables fast growth of a *pda1Δ ach1Δ* strain on glucose {#sec3-4}
---------------------------------------------------------------------------------------------------------

Under glucose-limited conditions, strain IMK640 (*pda1Δ ach1Δ*) does not show a mitochondrial acetyl-CoA deficiency when [l]{.smallcaps}-carnitine is added to the medium (Table [4](#tbl4){ref-type="table"}). However, in glucose-grown batch cultures of this strain, [l]{.smallcaps}-carnitine addition did not support wild-type growth rates (Table [2](#tbl2){ref-type="table"}), suggesting that the flux through the carnitine shuttle was limiting mitochondrial acetyl-CoA provision and thereby growth under these conditions. To test this hypothesis, expression cassettes were constructed with each of the components of the carnitine shuttle (*HNM1*, *AGP2*, *CRC1*, *YAT1*, *YAT2* and *CAT2*) placed under the control of a strong, constitutive promoter. The resulting six cassettes were integrated into the *SGA1* locus of strain IMX710 (*pda1Δ ach1Δ*) resulting in strain IMX744 (*pda1Δ ach1Δ sga1Δ::*{CARN}). Enzyme assays showed a high activity of carnitine acetyltransferase activity in cell extracts of glucose-grown batch cultures of the constitutively expressing carnitine shuttle strain IMX744 (3.56 ± 0.20 μmol⋅(mg protein)^−1^⋅min^−1^), while activity in reference strain IMX710 (*pda1Δ ach1Δ*) was below the detection limit (\<0.01 μmol⋅(mg protein)^−1^⋅min^−1^). Without [l]{.smallcaps}-carnitine supplementation, strain IMX744 showed similar growth rates as the *pda1Δ ach1Δ* reference strain IMX710, irrespective of the nitrogen source (Table [5](#tbl5){ref-type="table"}). However, when [l]{.smallcaps}-carnitine was added to the medium, the growth rate of IMX744 reached up to 79% of that of the *PDA1 ACH1* reference strain IMX585. These data show that in, the presence of [l]{.smallcaps}-carnitine, constitutive expression of the carnitine-shuttle genes indeed enables efficient transport of acetyl-units from the cytosol into the mitochondria in glucose-grown batch cultures.

###### 

Effect of the constitutive expression of carnitine shuttle genes on growth of *pda1Δ ach1Δ S. cerevisiae.* Strains were grown in shake flasks with synthetic medium and 20 g⋅L^−1^ glucose. As a nitrogen source, either 38 mM urea or 76 mM glutamate was used. Where indicated, [l]{.smallcaps}-carnitine was added at a final concentration of 400 mg⋅L^−1^. The data represent averages of at least two independent experiments. In all cases the mean deviation was ≤ 0.01 h^−1^.

                                              Specific growth rate (h^−1^)                 
  -------- ---------------------------------- ------------------------------ ------ ------ ------
  IMX585   *PDA1 ACH1*                        0.35                           0.37   0.34   0.37
  IMX710   *pda1Δ ach1Δ*                      0.10                           0.10   0.13   0.13
  IMX744   *pda1Δ ach1Δ* Carnitine shuttle↑   0.08                           0.09   0.27   0.25

A constitutively expressed carnitine shuttle does not affect respirofermentative metabolism in *PDA1 ACH1 S. cerevisiae* {#sec3-5}
------------------------------------------------------------------------------------------------------------------------

*Saccharomyces cerevisiae* is a Crabtree-positive yeast, using alcoholic fermentation as the predominant catabolic route in aerobic, glucose-grown batch cultures (De Deken [@bib11]). To test whether an alternative entry into the TCA cycle via PDH bypass and carnitine shuttle might affect the distribution of glucose carbon over respiration and fermentation in aerobic, glucose-grown batch cultures of *S. cerevisiae*, we constructed the *PDA1 ACH1* reference strain IMX868, which constitutively expressed the carnitine-shuttle genes. Enzyme assays in glucose-grown batch cultures confirmed overexpression of the carnitine acetyltransferases, showing an activity of 3.01 ± 0.03 μmol⋅rmg protein)^−1^⋅min^−1^, while activity in the reference strain IMX585 was below the detection limit (\<0.01 μmol⋅(mg protein)^−1^⋅min^−1^). Strain IMX868 (*PDA1 ACH1 sga1Δ::*{CARN}) was grown in aerobic bioreactor batch cultures with glucose as the carbon source, in the presence and absence of [l]{.smallcaps}-carnitine (Fig. [2](#fig2){ref-type="fig"}). During growth on glucose, the strain showed similar growth rates (0.39 ± 0.00 h^−1^) as the reference strain CEN.PK113-7D (0.37 ± 0.01 h^−1^; Van Maris *et al*. [@bib89]), when no [l]{.smallcaps}-carnitine was added. Upon [l]{.smallcaps}-carnitine supplementation, the growth rate slightly decreased, to 0.36 ± 0.00 h^−1^. Biomass and ethanol yields were highly similar in the absence and presence of [l]{.smallcaps}-carnitine, indicating that the presence of an active carnitine shuttle does not affect the balance between respiration and fermentation in aerobic batch cultures of *S. cerevisiae*.

![Impact of the constitutive expression of the carnitine shuttle on aerobic growth of *S. cerevisiae* on glucose in batch cultures. Growth of IMX868 ({CARN}) was analyzed in aerobic bioreactors on synthetic medium with an initial glucose concentration of 20 g⋅L^−1^ without (**a**) or with (**b**) 40 mg⋅L^−1^[l]{.smallcaps}-carnitine. Data shown in the graphs are from single batch experiments for each condition. Independent duplicate experiments for each condition gave essentially the same results. Biomass specific consumption (q~s~) and production rates (q~etOH~) are expressed in mmol⋅g~DW~^−1^, while yields are expressed in g⋅g^−1^.](fow017fig2){#fig2}

DISCUSSION {#sec4}
==========

Pyruvate and acetyl coenzyme A are key precursors for a wide variety of industrially relevant compounds produced by engineered *S. cerevisiae* strains (Pronk, Steensma and Van Dijken [@bib73]; Krivoruchko *et al*. [@bib53]; Lian and Zhao [@bib59]; Sheng and Feng [@bib78]). Design and implementation of metabolic engineering strategies to improve fluxes towards these precursors not only requires knowledge of flux distribution in wild-type strains, but also on compensatory 'back-up' pathways that become active when the mechanisms that carry the majority of the flux in wild-type cells are inactivated by genetic modification or by changing process conditions.

In previous work, the PDH complex was shown to be the predominant link between glycolysis and TCA cycle in slow growing, glucose-limited aerobic chemostat cultures, in which sugar dissimilation is exclusively respiratory (Wenzel *et al*. [@bib98]; Pronk *et al*. [@bib74]). In aerobic, glucose-grown batch cultures *S. cerevisiae* employs alcoholic fermentation as the main dissimilatory pathway (Polakis and Bartley [@bib71]; De Deken [@bib11]; Van Dijken, Weusthuis and Pronk [@bib87]). In such cultures, the major role of the TCA cycle is not the dissimilation of pyruvate, but the provision of precursors for assimilation. The near-wild type growth rates of a *cit2Δ ach1Δ* strain and the impaired growth of a *pda1Δ* strain in glucose-grown cultures with urea as the nitrogen source show that the combination of mitochondrial pyruvate uptake via the recently discovered Mpc1/Mpc2 'MpcFerm' mitochondrial carrier complex (Bender, Pena and Martinou [@bib3]) and its conversion by the PDH complex to acetyl-CoA is also the main entry into the TCA cycle during aerobic batch cultivation of *S. cerevisiae* on glucose (Table [2](#tbl2){ref-type="table"}).

By growing *S. cerevisiae* on glutamate as the sole nitrogen source, we were able to dissect the role of the PDH complex in the biosynthesis of TCA cycle intermediates from its role in the direct provision of intramitochondrial acetyl-CoA. In glucose-grown batch cultures of *S. cerevisiae*, glucose catabolism is almost completely fermentative (Van Dijken, Weusthuis and Pronk [@bib87]). Consequently, in glucose-urea medium, in which no direct precursors of TCA-cycle intermediates are available, the majority of the flux through the PDH complex will be directed towards the synthesis of TCA cycle-derived metabolic precursors. Under these conditions, cytosolic synthesis of citrate via Cit2 was shown as a key compensatory mechanism in the absence of a functional PDH complex, as evident from the very slow growth of the *pda1Δ cit2Δ* strain, which could be almost completely restored to wild-type levels when TCA-cycle intermediates were externally supplied by using glutamate instead of urea as the nitrogen source (Table [2](#tbl2){ref-type="table"}). The lack of a marked phenotype of a *cit2Δ* strain in glucose-grown batch cultures indicates that Cit2 does not have a major role in fueling the TCA cycle in wild-type cells. However, its transcriptional regulation pattern (*CIT2* is transcribed in glucose-grown batch cultures but repressed by glutamate; Kim, Rosenkrantz and Guarente [@bib44]) suggests that under certain conditions Cit2 may contribute to synthesis of TCA-cycle intermediates and/or cytosolic acetyl-CoA homeostasis in the presence of a functional PDH complex. This is consistent with previous findings that *CIT2* expression is controlled by the retrograde regulation pathway, a communication pathway between the nucleus and mitochondria (Liao *et al*. [@bib60]; Chelstowska and Butow [@bib9]; Liu and Butow [@bib61]). As a result of retrograde regulation, functional expression of *CIT2* is up-regulated when respiratory capacity is reduced or absent, and when the TCA cycle is blocked (Liao *et al*. [@bib60]; Chelstowska and Butow [@bib9]).

Cit2 is localized to the peroxisomes when proliferation of these organelles is induced by oleate (Lewin, Hines and Small [@bib58]). Its localization under other growth conditions is ambiguous, with several subcellular fractionation studies indicating an at least partial cytosolic localization in glucose-grown cultures (Duntze *et al*. [@bib17]; Perlman and Mahler [@bib70]; Rickey and Lewin [@bib75]). A clear carbon-source-dependent localization has previously been shown for the *MLS1*-encoded malate synthase, whose location is peroxisomal in oleate-induced cultures but cytosolic during growth on ethanol (Kunze *et al*. [@bib55]). Glucose-grown cultures of *S. cerevisiae* harbor only very few, small peroxisomes (Thieringer *et al*. [@bib82]). Moreover, Acs2, the only active acetyl-CoA synthetase isoenzyme in the presence of excess glucose due to the glucose repression of *ACS1* and glucose catabolite inactivation of Acs1, is nucleocytosolic (Van den Berg *et al*. [@bib84]; De Jong-Gubbels *et al*. [@bib12]). Since peroxisomal membranes are impermeable to acetyl-CoA (Van Roermund *et al*. [@bib90]), our results strongly indicate that, in *pda1Δ* strains in glucose-grown batch cultures, Cit2 is at least partially localized to the same compartment as Acs2. Although condition-dependent subcellular localization of Cit2 requires further study, the key role of Cit2 as a compensatory enzyme in *pda1Δ* mutants is fully consistent with a cytosolic localization in glucose-grown cultures.

Previous research on Ach1 mostly focused on its role during growth on ethanol and acetate, either as sole carbon sources or in their metabolism after the diauxic shift in glucose-grown cultures (Lee, Lin and Smith [@bib57]; Buu, Chen and Lee [@bib8]; Fleck and Brock [@bib23]; Orlandi, Casatta and Vai [@bib67]; Eisenberg *et al*. [@bib18]). Strains with *ACH1* deleted show impaired growth at high acetate concentrations, although growth on medium with ethanol is not affected (Buu, Chen and Lee [@bib8]; Fleck and Brock [@bib23]). Post-diauxic shift *ach1Δ* cultures show increased extracellular acetate accumulation and a reduced life span (Orlandi, Casatta and Vai [@bib67]; Eisenberg *et al*. [@bib18]). *ACH1* has been reported to be repressed by glucose (Lee, Lin and Smith [@bib57]), but in case of the reference strain CEN.PK113-7D, high mRNA levels are found in cultures grown under conditions of glucose repression (Knijnenburg *et al*. [@bib48]). Our growth experiments with glutamate as the nitrogen source indicated that Ach1 can replace the PDH complex in *pda1Δ* strains as the source of intramitochondrial acetyl-CoA for synthesis of arginine, leucine and lipoic acid (Table [2](#tbl2){ref-type="table"}). The impact of the impaired mitochondrial acetyl-CoA synthesis in *pda1Δ ach1Δ* strains became apparent from a strongly reduced growth rate and a spectacularly high incidence of respiratory deficient cells in glucose-grown batch cultures (Table [3](#tbl3){ref-type="table"}). A much less pronounced loss of respiratory deficiency was observed in previous experiments with *pda1Δ* strains (Wenzel *et al*. [@bib98]), which can now be interpreted from a partial compensation by Ach1. The strong impact of the *pda1Δ ach1Δ* strains on respiratory competence resembles the phenotypes of strains impaired in mitochondrial fatty acid synthesis (Harington *et al*. [@bib34]; Torkko *et al*. [@bib83]; Hiltunen *et al*. [@bib37]), which has been proposed to be essential for respiratory complex assembly (Kursu *et al*. [@bib56]) and requires mitochondrial acetyl-CoA. The frequent, irreversible loss of respiratory competence in these cells requires special measures in genetic modification and maintenance of *pda1Δ ach1Δ* strains. Use of non-fermentable carbon sources, as applied in this study, and/or inclusion of [l]{.smallcaps}-carnitine in growth media offer simple measures to minimize the frequency of respiratory-deficient mutants in stock cultures.

Glutamate also restores growth of *Kluyveromyces lactis pda1Δ* strains to near-wild type levels (Zeeman *et al*. [@bib101]), suggesting that this yeast also harbors at least one compensatory pathway for synthesis of intramitochondrial acetyl-CoA. Indeed, the *K. lactis* genome harbors a gene with 82% sequence identity of its gene product with Ach1 (Dujon *et al*. [@bib16]). A recent study has demonstrated that, in addition to providing acetyl-CoA in the mitochondrial matrix, Ach1 can also play a role in another compensatory process. In pyruvate-decarboxylase-negative strains, where the PDH bypass cannot meet the cellular demand for cytosolic acetyl-CoA, Ach1 can generate acetate from mitochondrial acetyl-CoA. After its export to the cytosol and activation to acetyl-CoA, this enables growth of Pdc^−^*S. cerevisiae* on glucose without addition of a C2 source (Chen *et al*. [@bib10]). These orthogonal roles suggest that Ach1 can play an important, flexible role in cytosolic and mitochondrial acetyl-CoA homeostasis. The ubiquitous presence of sequences homologous to *ACH1* in a large group of fungal genomes (Buu, Chen and Lee [@bib8]; Wapinski *et al*. [@bib97]; Fleck and Brock [@bib23]; Wapinski [@bib96]), indicates that this role may be widespread among fungi.

An *S. cerevisiae* strain in which the PDH complex, Ach1 and Cit2 were all absent still showed a low, residual growth rate (Table [2](#tbl2){ref-type="table"}). This observation indicates that *S. cerevisiae* harbors either another mechanism for intramitochondrial acetyl-CoA synthesis or a pathway that circumvents its necessity. One explanation could be a partial targeting of an acetyl-CoA synthetase isoenzyme to the mitochondrial matrix. Although most studies indicate an extramitochondrial localization of Acs1 and Acs2 (Kispal *et al*. [@bib45]; Huh *et al*. [@bib40]; Takahashi *et al*. [@bib81]; Koh *et al*. [@bib49]), there are also reports that Acs1 is localized to the mitochondria (Klein and Jahnke [@bib47]; Kumar *et al*. [@bib54]). However, deletion of the *ACS1* ORF in IMK641 (resulting in a *pda1Δ cit2Δ ach1Δ acs1Δ* genotype) did not result in a lower growth rate than already observed for the *pda1Δ cit2Δ ach1Δ* strain (data not shown). Based on enzymatic analysis, it was previously hypothesized that *S. cerevisiae* may harbor a 2-oxoacid dehydrogenase to catabolyse branched-chain amino acids to mitochondrial acetyl-CoA (Dickinson and Dawes [@bib15]). However, after this yeast was sequenced, it became clear that it does not contain the genes encoding the subunits for this complex (Goffeau *et al*. [@bib31]; Nijkamp *et al*. [@bib66]). The residual growth rate of the *pda1Δ cit2Δ ach1Δ* strain illustrates that, even at the interface of the two most intensively studied pathways in central metabolism, our knowledge of pathway topology remains incomplete.

In contrast to the situation in *S. cerevisiae* (Table [2](#tbl2){ref-type="table"}), [l]{.smallcaps}-carnitine addition restored growth of a *K. lactis pda1Δ* strain to near wild-type levels (Zeeman *et al*. [@bib101]), suggesting that, in the latter yeast, the carnitine shuttle genes are not, or not as strongly, repressed by glucose as in the former. Indeed, under glucose-derepressed conditions in chemostat cultures, [l]{.smallcaps}-carnitine addition could restore respiratory growth of an *S. cerevisiae pda1Δ ach1Δ* strain in glucose-limited chemostats (Table [4](#tbl4){ref-type="table"}). Constitutive expression of the genes involved in the carnitine shuttle strongly stimulated growth of a *pda1Δ ach1Δ* strain in the presence of [l]{.smallcaps}-carnitine (Table [5](#tbl5){ref-type="table"}), indicating that there are no post-translational or allosteric regulation mechanisms that prevent this shuttle from operating in glucose-containing media. However, the incomplete (77%) recovery of the wild-growth rate may reflect a remaining limitation in this pathway in *S. cerevisiae*. This study demonstrates, for the first time, that the entire carnitine shuttle in this yeast can be functionally overexpressed. We therefore also investigated its impact in a 'wild type' *PDA1 ACH1 CIT2* reference strain (Fig. [2](#fig2){ref-type="fig"}). This experiment indicated that a mere facilitation of the entry of acetyl-CoA into the TCA cycle does not affect the balance between respiration and fermentation in aerobic, glucose-grown batch cultures of *S. cerevisiae*. Glucose repression of other key genes in respiratory glucose metabolism, e.g. those encoding TCA cycle and mitochondrial respiratory chain proteins, constrains the respiratory capacity under these conditions (Gancedo [@bib29]; Fendt and Sauer [@bib22]). We anticipate that *S. cerevisiae* strains with a constitutively expressed carnitine shuttle will prove to be valuable tools for studies on metabolic engineering of *de novo*[l]{.smallcaps}-carnitine synthesis in this yeast (Franken *et al*. [@bib26]) and on the requirements for *in vivo* reversibility of the mitochondrial carnitine shuttle (Ventura *et al*. [@bib93]; Violante *et al*. [@bib95]).
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